Recombinant Antibody Fragments for Neurodegenerative Diseases.
about
Recent advances in treating Parkinson's disease.Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential.Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells.
P2860
Recombinant Antibody Fragments for Neurodegenerative Diseases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Recombinant Antibody Fragments for Neurodegenerative Diseases.
@en
type
label
Recombinant Antibody Fragments for Neurodegenerative Diseases.
@en
prefLabel
Recombinant Antibody Fragments for Neurodegenerative Diseases.
@en
P2093
P2860
P921
P1476
Recombinant Antibody Fragments for Neurodegenerative Diseases.
@en
P2093
Goar Gevorkian
Karen Manoutcharian
Roxanna Perez-Garmendia
P2860
P304
P356
10.2174/1570159X01666160930121647
P5008
P577
2016-09-30T00:00:00Z